Kolexia
Decaux Olivier Médecine interne
Decaux Olivier
Médecine interne
Hôpital Pontchaillou
Rennes, France
331 Activités
7 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Myélome multiple Vascularite Paraprotéinémies Tumeurs à plasmocytes Vascularites associées aux anticorps anti-cytoplasme des neutrophiles Myélome multiple indolent Maladies auto-immunes Granulomatose avec polyangéite Récidive tumorale locale

Collaborateurs

Voir plus
Leleu Xavier
Leleu Xavier
Hôpital La Miletrie, Poitiers, France
Moreau Philippe
Moreau Philippe
Hôpital Hôtel-Dieu Nantes, Nantes, France
Hulin Cyrille
Hulin Cyrille
Hôpital Haut-lévêque, Pessac, France
Macro Margaret
Macro Margaret
Hôpital Côte de Nacre, Caen, France

Industries

Voir plus
Janssen
27 collaboration(s)
Dernière en 2023
Edimark
26 collaboration(s)
Dernière en 2023
Sanofi
14 collaboration(s)
Dernière en 2023
Celgene
9 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
RHUMM: Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma RHU(M)M Random or H24 Urine in (Multiple) Myeloma
Essai Clinique (Intergroupe Francophone du Myélome)   15 mars 2024
IsAMYP: A Phase 2, Open Label, Multicenter, Single-stage Study to Evaluate the Efficacy of Isatuximab Plus Pomalidomide and Dexamethasone (IPd), in Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
Essai Clinique (BMS)   05 mars 2024
Journées AIH 2023 : Prise en charge du myélome multiple chez le sujet très âgé
Youtube @ Association des Internes en Hématologie AIH   30 décembre 2023
Real-life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study.
EJHaem   13 décembre 2023
Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group.
Thrombosis research   02 décembre 2023
Ixazomib, Pomalidomide and Dexamethasone (IxPd) in Relapsed or Refractory Multiple Myeloma (RRMM) Characterized with High-Risk Cytogenetics. IFM 2014-01
65th ASH Annual Meeting Abstracts   02 novembre 2023
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone Induction and Consolidation with Tandem Transplant in High-Risk Newly Diagnosed Myeloma Patients: Final Results of the Phase 2 Study IFM 2018-04
65th ASH Annual Meeting Abstracts   02 novembre 2023
Multicenter Open Label Phase 2 Study of Quadruplet-Based Regimen Iskpd (isatuximab plus pomalidomide and dexamethasone with carfilzomib) in Early Relapsed or Refractory Multiple Myeloma - IFM2018-03
65th ASH Annual Meeting Abstracts   02 novembre 2023
French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): Update of the IFM Study from the Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Real-World Outcomes of Newly Diagnosed Multiple Myeloma (NDMM) Patients Treated before the Anti-CD38 Antibodies Era in France, the Emmy Cohort 2017 to 2020
65th ASH Annual Meeting Abstracts   02 novembre 2023